Proposal for the creation of a national strategy for precision medicine in cancer: a position statement of SEOM, SEAP and SEFH
Calleja, Miguel Ángel
Álava, Enrique de
Lamas, María Jesús
MetadataShow full item record
Precision medicine is an emerging approach for disease treatment and prevention that takes into account individual variability in genes, environment, and lifestyle for each person. Precision medicine is transforming clinical and biomedical research, as well as health care itself from a conceptual, as well as a methodological viewpoint, providing extraordinary opportunities to improve public health and lower the costs of the healthcare system. However, the implementation of precision medicine poses ethical-legal, regulatory, organizational and knowledge-related challenges. Without a national strategy, precision medicine, which will be implemented one way or another, could take place without the appropriate planning that can guarantee technical quality, equal access of all citizens to the best practices, violating the rights of patients and professionals and jeopardizing the solvency of the healthcare system. With this paper from the Spanish Societies of Medical Oncology (SEOM), Pathology (SEAP), and Hospital Pharmacy (SEFH) we highlight the need to institute a consensual national strategy for the development of precision medicine in our country, review the national and international context, comment on the opportunities and challenges for implementing precision medicine, and outline the objectives of a national strategy on precision medicine in cancer.
Is part ofFarmacia Hospitalaria, 2017, vol. 41, núm. 61, p. 688-691
European research projects
The following license files are associated with this item:
Except where otherwise noted, this item's license is described as cc-by-nc-nd (c) Garrido et al., 2017
Showing items related by title, author, creator and subject.
Proposal for the creation of a national strategy for precisionmedicine in cancer: a position statement of SEOM, SEAP,and SEFH Garrido, Pilar; Aldaz, Azucena; Vera, Ruth; Calleja, Miguel Ángel; Álava, Enrique de; Martín, Miguel; Matias-Guiu, Xavier; Palacios, José (Springer, 2018)Precision medicine is an emerging approach for disease treatment and prevention that takes into account individual variability in genes, environment, and lifestyle for each person. Precision medicine is transforming ...
Fernandez Jaén, Tomas; Álvarez Rey, Guillermo; Angulo, Francisco; Ardevol Cuesta, Jordi; Arriaza Loureda, Rafael; Ávila España, Fernando; Ayala, Juan; Balius Matas, Ramón; Baró Pazos, Fernando; Dios Beas Jiménez, Juan de; Candel Rosell, Jorge; Cobián Fernandez, César; Doñoro Cuevas, Mª del Pilar; Esparza Ros, Francisco; Espejo Colmenero, Josefina; Fernández de Prado, Jorge; García Cota, Juan José; Garrido González, Jose Ignacio; Gonzalez de Vega, Carlos; González Santander, Manuela; Herrador Munilla, Miguel Ángel; Ivorra Ruiz, Francisco; Jiménez Díaz, Fernando; Maestro Fernandez, Antonio; Manonelles Marqueta, Pedro; Muñoz Benito, Juan Jose; Olivé Vilás, Ramón; Pedret, Carles; Peirau i Terés, Xavier; Peña Amaro, José; Puigdellivoll Grifell, Jordi; Pérez San Roque, Juan; Ramírez Parenteu, Christophe; Ribas Serna, Juan; Rodas, Gil; Sánchez Álvarez, Mikel; Sanchez Marchori, Carlos; Til Perez, Lluis; Ureña Durán, Rosario; Valle Soto, Miguel de; Villalón Alonso, José María; Guillen García, Pedro; Spanish Group for Tendon Consensus (Sage, 2017)On October 15, 2016, experts met at Clínica CEMTRO in Madrid, Spain, under the patronage of the Spanish Society for Sports Traumatology (SETRADE), the Spanish Society of Sports Medicine (SEMED), the Spanish Association of ...
2018 consensus statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology on the diagnosis and treatment of cancer of unknown primary Losa, F.; Iglesias, L.; Pané, M.; Sanz, J.; Nieto, B.; Fusté, V.; de la Cruz‑Merino, L.; Concha, Á.; Balañá, Carme; Matias-Guiu, Xavier (Springer, 2018)Cancer of unknown primary (CUP) is defned as a heterogeneous group of tumours that present with metastasis, and in which attempts to identify the original site have failed. They difer from other primary tumours in their ...